Efficacy and safety of abatacept to treat active birdshot uveitis: a prospective open label interventional proof-of-concept trial.

Schauwvlieghe PP, Van Calster J, Herbort CP Jr, Kestelyn PA, de Vlam K

Open source

DOI
10.1136/bjo-2022-321585
Published
2024 Jan 29
Container
The British journal of ophthalmology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1136/bjo-2022-321585,
  title = {Efficacy and safety of abatacept to treat active birdshot uveitis: a prospective open label interventional proof-of-concept trial.},
  author = {Schauwvlieghe PP and Van Calster J and Herbort CP Jr and Kestelyn PA and de Vlam K},
  year = {2024},
  journal = {The British journal of ophthalmology},
  doi = {10.1136/bjo-2022-321585},
  url = {https://doi.org/10.1136/bjo-2022-321585}
}

RIS

TY  - JOUR
TI  - Efficacy and safety of abatacept to treat active birdshot uveitis: a prospective open label interventional proof-of-concept trial.
AU  - Schauwvlieghe PP
AU  - Van Calster J
AU  - Herbort CP Jr
AU  - Kestelyn PA
AU  - de Vlam K
PY  - 2024
JO  - The British journal of ophthalmology
DO  - 10.1136/bjo-2022-321585
UR  - https://doi.org/10.1136/bjo-2022-321585
ER  - 

APA

PP, S., J, V. C., Jr, H. C., PA, K., & K, D. V. (2024). Efficacy and safety of abatacept to treat active birdshot uveitis: a prospective open label interventional proof-of-concept trial.. The British journal of ophthalmology. https://doi.org/10.1136/bjo-2022-321585

Source records